Compare EL & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EL | CNC |
|---|---|---|
| Founded | 1946 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.4B | 21.5B |
| IPO Year | 2007 | 2001 |
| Metric | EL | CNC |
|---|---|---|
| Price | $67.52 | $32.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 17 |
| Target Price | ★ $103.38 | $41.94 |
| AVG Volume (30 Days) | 4.9M | ★ 5.6M |
| Earning Date | 04-30-2026 | 04-24-2026 |
| Dividend Yield | ★ 2.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.57 | N/A |
| Revenue | $14,326,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $7.68 | $8.29 |
| Revenue Next Year | $4.21 | $1.26 |
| P/E Ratio | $122.08 | ★ N/A |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $48.37 | $25.08 |
| 52 Week High | $121.64 | $66.03 |
| Indicator | EL | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 20.67 | 29.50 |
| Support Level | $67.11 | $25.08 |
| Resistance Level | $93.17 | $33.44 |
| Average True Range (ATR) | 4.11 | 1.51 |
| MACD | -1.81 | -0.36 |
| Stochastic Oscillator | 0.53 | 2.77 |
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%). Top selling brands include Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.